A Case Report of Pulmonary Exacerbation after Initiation of Lumacaftor/Ivacaftor Therapy in a CF Female with Complicated Lung Disease

Novel targeted treatments for Cystic Fibrosis give rise to new hope for an ever-growing number of CF patients with various mutations. However, very little evidence and guidelines exist to steer clinical decisions regarding patients whose illness takes an unexpected course. In such cases, the benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatziagorou, Elpis, Kouroukli, Eleana, Georgopoulou, Vasiliki, Tsanakas, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998152/
https://www.ncbi.nlm.nih.gov/pubmed/30002941
http://dx.doi.org/10.1155/2018/8394370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998152/
https://www.ncbi.nlm.nih.gov/pubmed/30002941
http://dx.doi.org/10.1155/2018/8394370

Ejemplares similares